|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.390 USD | -14.11% |
|
-10.00% | -27.55% |
| May. 07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| May. 06 | Vanda Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 384M | - | - | - | ||
| 49.13B | |||||
| 49.58B | |||||
| 22.66B | - | ||||
| 23.52B | - | ||||
| 17.59B |
Select your edition
All financial news and data tailored to specific country editions
